PR Newswire - Kexing Biopharm Obtained Clinical Trial Approval f...
SHENZHEN, China, May 30, 2024 /PRNewswire/ -- On the 24th of May, Kexing Biopharm (688136.SH) announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a ...
Read More

ภาษาไทย
English